Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) Genotyping
The HPRT1 gene is located at Xq26.2-6.3 and encodes for hypoxanthine phosphoribosyltransferase 1 (HPRTase). The enzyme belongs to the transferase class of enzymes and is important in the salvage pathway of nucleotide synthesis. During purine degradation to uric acid, HPRTase converts hypoxanthine to inosine monophosphate (IMP) and guanine to guanosine monophosphate (GMP). IMP and GMP can then be utilized in new purine synthesis. Mutations in the HPRT1 gene may lead to diminished activity or deficiency of HPRTase and the hypoxanthine and guanine formed during the purine degradation are shunted to form xanthine and ultimately end up as uric acid.
Such mutations in the HPRT1 gene result in Lesch-Nyhan syndrome in males which is characterized by hyperuricemia and neurological manifestations. Females who inherit a mutated HPRT1 are clinically normal but may pass the disorder to their male offspring. Rarely, females with Turners syndrome or non-rasndom mX-chromosome inactivation may devedlop the lesch-Nyhan phenotype. Hyperuricemia results in renal calculus formation and renal damage as well as gouty arthritis. Neurological manifestations in patients with Lesch-Nyhan syndrome include dystonia, congnitive disorders, and most importantly, self-harming behaviors.
Lesch-Nyhan syndrome occurs in approximately 1 in 380,000 births and over 400 mutations on the HPRT1 gene have been associated with the disease. The treatment of patients involves the management of hyperuricemia with allopurinol and neurological manifestations with benzodiazepines or GABA-inhibitors.
- Aids in the diagnosis of Lesch-Nyhan syndrome
- Useful in the investigation of hyperuricemia with or without neurological manifestations
- Can be used for prenatal and family members at risk screening
A positive result indicates the presence of mutations in the HPRT1 gene thus indicative of Lesch-Nyhan syndrome.
A negative result indicates the absence of mutations in the HPRT1 gene and rules out the diagnosis of Lesch-Nyhan syndrome.
Other causes of hyperuricemia and neurological manifestations should be investigated.
Negative for mutations analysis (no mutations or pathogenic variants detected)
Whole blood, EDTA (Lavender-top tube).
Stability
- Ambient: 3 days
- Refrigerated: 1 week
- Frozen: 1 month
- Orphanet J Rare Dis. 2007 Dec 8;2:48. [PMID: 18067674]
- Rev Clin Esp (Barc). 2014 Nov;214(8):459-60. [PMID: 24893700]
- Brain. 2014 May;137(Pt 5):1282-303. [PMID: 23975452]
- Nucleosides Nucleotides Nucleic Acids. 2016 Aug 2;35(8):426-33. [PMID: 27379977]
- GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022. [PMID: 20301328]